Arthritis, rheumatoid Trials in Victoria, Canada
Conditions / Arthritis, rheumatoid / Victoria, Canada
Clinical trials for Arthritis, rheumatoid investigate a range of treatment strategies and patient populations.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00413699 | Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT00847613 | A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate | COMPLETED | PHASE3 |
| NCT00042068 | A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT00346216 | Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen | COMPLETED | PHASE4 |
| NCT00113308 | COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT02092467 | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT01856309 | Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 | COMPLETED | PHASE3 |
| NCT01604343 | A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D) | COMPLETED | PHASE3 |
| NCT01606761 | A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) | COMPLETED | PHASE3 |
| NCT01039688 | Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX | COMPLETED | PHASE3 |